Closing the AI Perception Gap
A perspective from Fulcrum Research Group A recent article from bi.team explored an idea that immediately resonated with us: people tend to believe AI […]
Why Patient Journey Research Shouldn’t End with a PowerPoint
Every pharmaceutical company conducts research to better understand patients. Then, more often than not, those insights live on a shared
Targeting the Totality of MS: Jason Tardio on Immunic’s Combined Neuroprotective & Anti-Inflammatory Strategy
Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Jason Tardio, President and
The Future of Psychedelic Medicine: Clinical Strategy and Scaling Access.
Welcome to a special edition of IDEA Collider’s “Deep Medicine” series. In this episode, host Alex Gray sits down with
The Power of the Early Narrative: Sue Wood on Strategic Biotech Positioning
Welcome to IDEA Collider with your host, Rick Ritacco. In this episode, we sit down with Sue Wood, a senior
How I Learned to Love My ATU
Our Best Practices for Tracking Research. Tracking research is a foundational part of any market research plan. Studies under the
Accurate Product Forecasting
An accurate prediction of future market share can help optimize strategy beyond sales and marketing, impacting decisions as far-reaching as
Choose Your Own Adventure
A unique Market Research approach to inform rare disease education. The Challenge. One of the common challenges orphan drug makers
Using Archetypes to Understand Prescribing Decisions
Healthcare marketing now recognizes that prescribing decisions—like all decisions—are never purely rational. But the search to identify heuristics and other
How and Why to Execute Rare Disease Patient Journey Market Research
We all appreciate the importance of empathy in patient interactions. However, this understanding is even more important in the world